This study aims to compare two medications, retatrutide and semaglutide, to see how well they work and how safe they are for people with Type 2 Diabetes who don't manage their blood sugar well with metformin. Type 2 Diabetes is a condition where the body doesn't use insulin properly, leading to high blood sugar. Metformin is a common medicine for diabetes, and some participants may also use an SGLT2 inhibitor, another type of diabetes medication that helps the kidneys remove sugar from the body. The study will last about 26 months and could include up to 24 visits to the study site.
- This study lasts for 26 months with up to 24 visits.
- Participants must have Type 2 Diabetes and stable weight.
- People with Type 1 Diabetes or certain health issues cannot join.